Concepedia

Charles Link

CL

Statistics

Publications

22

Citations

1.2K

H-Index

18

Active since

1977

Affiliations

NewLink Genetics (United States)(Current)

Northwestern University

National Cancer Institute

Moffitt Cancer Center

Iowa State University

Charles Link is an author at NewLink Genetics (United States) specializing in medicine, oncology, and pharmacology.

Publications per year

1977–2020

22

Publications

22

Dose-Intense Taxol: High Response Rate in Patients With Platinum-Resistant Recurrent Ovarian Cancer

Elise C. Kohn, Gisele Sarosy, Annette Bicher et al. · JNCI Journal of the National Cancer Institute · 1994 · 193 citations

, , +17

A first in man phase I trial of the oral immunomodulator, indoximod, combined with docetaxel in patients with metastatic solid tumors

Hatem Soliman, Erica L. Jackson, Tony Neuger et al. · Oncotarget · 2014 · 171 citations · Full text

, , +7

A phase I study of indoximod in patients with advanced malignancies

Hatem Soliman, Susan Minton, Hyo S. Han et al. · Oncotarget · 2016 · 144 citations · Full text

, , +6

Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study

D. Gray Heppner, Tracy Kemp, Brian K. Martin et al. · The Lancet Infectious Diseases · 2017 · 121 citations · Full text

, , +14

Embryonic Stem Cells As an Alternate Marrow Donor Source

Richard K. Burt, Larissa Verda, Duck-An Kim et al. · The Journal of Experimental Medicine · 2004 · 111 citations · Full text

, , +17

1–5 of 22